T1	p 90 167	healthy volunteers and in patients with primary hypothyroidism . Somatostatin
T2	p 385 398	man has never
T3	p 471 569	in 8 healthy volunteers , and 6 women with untreated primary hypothyroidism , a disease state that
T4	p 1916 1973	subjects and in patients with primary hypothyroidism , it
T5	p 2087 2090	man
T6	i 18 45	somatostatin ( octreotide )
T7	i 67 76	melatonin
T8	i 155 167	Somatostatin
T9	i 321 333	somatostatin
T10	i 451 460	melatonin
T11	i 622 631	melatonin
T12	i 719 755	saline or octreotide ( Sandostatin ;
T13	i 781 782	)
T14	i 842 852	octreotide
T15	i 855 864	melatonin
T16	i 929 935	saline
T17	i 1126 1141	octreotide ( GH
T18	i 1173 1183	octreotide
T19	i 1329 1339	octreotide
T20	i 1510 1520	octreotide
T21	i 1557 1567	octreotide
T22	i 1655 1665	octreotide
T23	i 1756 1768	somatostatin
T24	i 1777 1802	exogenous somatostatin --
T25	i 1818 1828	octreotide
T26	i 1896 1905	melatonin
T27	i 2014 2026	somatostatin
T28	o 599 618	nocturnal secretion
T29	o 947 967	urinary excretion of
T30	o 1046 1058	GH secretion
T31	o 1292 1321	nocturnal melatonin secretion
T32	o 1353 1373	Urinary excretion of
T33	o 1417 1468	GH secretion . The total nocturnal secretion of TSH
T34	o 1527 1530	AUC